Gsa Capital Partners LLP Reata Pharmaceuticals Inc Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$126.3 - $176.56 $410,096 - $573,290
-3,247 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$124.16 - $247.74 $235,531 - $469,962
1,897 Added 140.52%
3,247 $469,000
Q4 2019

Feb 12, 2020
BUY
$74.57 - $217.92 $100,669 - $294,192
1,350 New
1,350 $276,000
Q1 2018

May 11, 2018
SELL
$20.0 - $30.19 $526,000 - $793,997
-26,300 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$22.39 - $33.27 $588,857 - $875,001
26,300
26,300 $745,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email